Eyenovia Payables Turnover from 2010 to 2025

EYEN Stock  USD 1.76  0.25  16.56%   
Eyenovia Payables Turnover yearly trend continues to be very stable with very little volatility. Payables Turnover is likely to drop to 0. Payables Turnover is a liquidity ratio that shows how quickly Eyenovia pays off its suppliers by dividing total purchases by average accounts payable. View All Fundamentals
 
Payables Turnover  
First Reported
2010-12-31
Previous Quarter
0.001944
Current Value
0.001847
Quarterly Volatility
0.26555555
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Eyenovia financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eyenovia's main balance sheet or income statement drivers, such as Interest Income of 661.2 K, Depreciation And Amortization of 945.7 K or Interest Expense of 2.9 M, as well as many indicators such as Price To Sales Ratio of 1.7 M, Dividend Yield of 0.0 or PTB Ratio of 1.2 K. Eyenovia financial statements analysis is a perfect complement when working with Eyenovia Valuation or Volatility modules.
  
Check out the analysis of Eyenovia Correlation against competitors.
To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.

Latest Eyenovia's Payables Turnover Growth Pattern

Below is the plot of the Payables Turnover of Eyenovia over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Eyenovia's Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eyenovia's overall financial position and show how it may be relating to other accounts over time.
Payables Turnover10 Years Trend
Pretty Stable
   Payables Turnover   
       Timeline  

Eyenovia Payables Turnover Regression Statistics

Arithmetic Mean0.14
Geometric Mean0.03
Coefficient Of Variation196.33
Mean Deviation0.17
Median0.04
Standard Deviation0.27
Sample Variance0.07
Range0.9894
R-Value0.24
Mean Square Error0.07
R-Squared0.06
Significance0.37
Slope0.01
Total Sum of Squares1.06

Eyenovia Payables Turnover History

2025 0.001847
2024 0.001944
2023 0.00216
2022 0.22
2021 0.99
2020 0.55
2019 0.009954

About Eyenovia Financial Statements

Eyenovia investors utilize fundamental indicators, such as Payables Turnover, to predict how Eyenovia Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year

Pair Trading with Eyenovia

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eyenovia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will appreciate offsetting losses from the drop in the long position's value.

Moving against Eyenovia Stock

  0.84OPT OptheaPairCorr
  0.75VERV Verve TherapeuticsPairCorr
  0.74LTRN Lantern PharmaPairCorr
  0.57FENC Fennec PharmaceuticalsPairCorr
  0.52TMO Thermo Fisher ScientificPairCorr
The ability to find closely correlated positions to Eyenovia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eyenovia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eyenovia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eyenovia to buy it.
The correlation of Eyenovia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eyenovia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eyenovia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eyenovia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Eyenovia offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eyenovia's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eyenovia Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eyenovia Stock:
Check out the analysis of Eyenovia Correlation against competitors.
To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyenovia. If investors know Eyenovia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyenovia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(55.20)
Revenue Per Share
0.047
Quarterly Revenue Growth
0.356
Return On Assets
(0.80)
Return On Equity
(3.88)
The market value of Eyenovia is measured differently than its book value, which is the value of Eyenovia that is recorded on the company's balance sheet. Investors also form their own opinion of Eyenovia's value that differs from its market value or its book value, called intrinsic value, which is Eyenovia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyenovia's market value can be influenced by many factors that don't directly affect Eyenovia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eyenovia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyenovia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyenovia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.